Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Wang C et al. | 2019 | - | signals/pulses, 50/60 Hz, magnetic field | - |
Pooam M et al. | 2017 | - | 50/60 Hz, magnetic field | - |
García-Minguillán O et al. | 2019 | - | magnetic field, low frequency, 50/60 Hz | - |
Di Carlo A et al. | 2002 | animal, chicken embryos/White Leghorn, whole body | microwaves, magnetic field, 50/60 Hz | 8 µT |
Rodriguez-De la Fuente AO et al. | 2012 | animal, mouse/BALB/c (quadriceps muscle transfected with an EMF plasmid) | magnetic field, low frequency, 50/60 Hz, co-exposure | 80 µT |
Villarini M et al. | 2013 | animal, mouse/CD-1, whole body | magnetic field, 50/60 Hz | 0.1–2 mT |
Harry GJ et al. | 2000 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 2 µT–1 mT |
George I et al. | 2008 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz | 8 µT |
Del Re B et al. | 2006 | bacterium, <i>Escherichia coli</i> | magnetic field, signals/pulses, 50/60 Hz | 1 mT |
Del Re B et al. | 2009 | bacterium, <i>Escherichia coli</i>/DH5alpha (untransformed (showing regular heat shock response) and transformed with two different plasmids inducing high transposition activity and an impaired response to heat shock) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Chow KC et al. | 2000 | bacterium, <i>Escherichia coli</i>/XL1-Blue | magnetic field, 50/60 Hz | 1.2 mT |
Coulton LA et al. | 2004 | blood samles | magnetic field, 50/60 Hz | 20–100 µT |
Kang KI et al. | 1998 | intact cell/cell culture, 34i cell line (derived from C3H mouse mammary epithelial carcinoma cells) | magnetic field, 50/60 Hz | 300–3,000 µT |
Czyz J et al. | 2004 | intact cell/cell culture, D3 (murine embryonic stem cell line, p53-deficient and wild type) | magnetic field, 50/60 Hz, power transmission line | 100 µT–2.3 mT |
Carmody S et al. | 2000 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard), invertebrate, eggs from <i>Sciara coprophila</i> | magnetic field, 50/60 Hz | 8 µT |
Tsurita G et al. | 1999 | intact cell/cell culture, HBL-100 (human breast cancer cell line), HeLa cell line (human adenocarcinoma cell line) and MCF-7 cells (human breast cancer cell line) | magnetic field, signals/pulses, 50/60 Hz, co-exposure | 34 mT |
Lin H et al. | 1998 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz | 8 µT |
Tokalov SV et al. | 2004 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, low frequency, 50/60 Hz | 10 µT |
Gottwald E et al. | 2007 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells); H9c2 (rat heart myoblast cells); Girardi cells (human heart cells) | magnetic field, 50/60 Hz | 2 µT–4 mT |
Lin H et al. | 1997 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 8 µT |
Miyakoshi J et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, co-exposure | 500 µT–50 mT |
Morehouse CA et al. | 2000 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz | 6.3–8 µT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 60 µT |
Goodman R et al. | 1994 | intact cell/cell culture, HL-60 cells (human acute myeloid leukaemia cell line) and yeast cells (<i>Saccharomyces cerevisiae</i>) | electric field, magnetic field, 50/60 Hz | 0.1–80 µT |
Han L et al. | 1998 | intact cell/cell culture, HTB124 cells (normal human breast cells) | magnetic field, 50/60 Hz | 8–80 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.